Independent Financial Information Made Easy
The development of Artificial Intelligence (AI) is modifying the way investments are evaluated. We programmed an artificial intelligence (A.I.) to summarize the whole internet. Whether you’re trying to make money investing online, making financial decisions or just getting informed about Wall Street, this page is a way to get informed without reading hundred of pages. Our stock market summary graphs are produced using machine learning, an unbiased view to capture what internet is saying. Usually, the AI reads several hundred pages and summarize it to a short text and several charts.
Open: 0.24 Close: 0.25 Change: 0.02
How much time have you spent trying to decide whether investing in GT Biopharma? Many investors start with the dream of being free. They expect to find on the stock market an option to have time to develop their own interests and hobbies. That is, a way to escape a 9 to 5 job. However, investment is complex and investors end up spending whole days (and nights) trying to figure out which the right stock to invest is. The dream of stock investing becomes the nightmare of facing infinity amounts of information. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about GT Biopharma are: …
GT Biopharma, Inc. focuses on the development and commercialization of immuno-oncology products. It develops GTB-3550, a single-chain tri-specific recombinant fusion protein conjugate. GT.
GT Biopharma Inc (GTBP) stock has fallen -2.67% while the S&P 500 has gained 0.04% as of 11:29 AM on Thursday, Oct 12. GTBP stock has a Bullish sentiment reading.
GT Biopharma Inc (GTBP) stock has fallen -2.67% while the S&P 500 has gained 0.04% as of 11:29 AM on Thursday, Oct 12. GTBP stock has a Bullish sentiment reading.
"GT Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology products based on its proprietary Tri-specific Killer Engager (TriKE) fusion protein immune cell engager technology platform. It develops GTB-3550, a single-chain tri-specific recombinant fusion protein conjugate that is in Phase I clinical trial for the treatment of myelodysplastic syndromes, refractory/relapsed acute myeloid leukemia or advanced systemic mastocytosis, and CD33+ malignancies. The company is developing GTB-3650, which is in preclinical studies that target CD33 on the surface of myeloid leukemias; and GTB-5550 that is in preclinical studies for treating patients with B7-H3 positive solid tumors. GT Biopharma, Inc. has a co-development partnership agreement with Altor BioScience Corporation for the clinical development of a 161533 TriKE fusion protein for cancer therapies; and a license agreement with the Regents of the University of Minnesota to develop and commercialize cancer therapies using TriKE technology. The company was formerly known as OXIS International, Inc. and changed its name to GT Biopharma, Inc. in July 2017. GT Biopharma, Inc. was incorporated in 1965 and is based in Brisbane, California."
The game is changing. There is a new strategy to evaluate GT Biopharma fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about GT Biopharma are: GTBP, stock, GT, Biopharma, Inc, fall, SP, and the most common words in the summary are: state, united, excipient, phase, therapeutic, sodium, overview, . One of the sentences in the summary was: GTBP stock has a Bullish sentiment reading.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #state #united #excipient #phase #therapeutic #sodium #overview.
Read more →Open: 0.24 Close: 0.24 Change: 0.0
Read more →Open: 0.37 Close: 0.36 Change: -0.01
Read more →Open: 0.24 Close: 0.25 Change: 0.02
Read more →